Role for EPS8 in squamous carcinogenesis.

We have investigated the role of the signaling intermediate, EPS8, in tumor progression using a model system and in vivo. HN4 primary tumor cells express low levels of EPS8, similar to normal keratinocytes, and show minimal invasion in vitro in response to epidermal growth factor, whereas HN12 cells express high levels of EPS8 and are highly motile in vitro and tumorigenic in vivo. Additional independent tumor cell lines also showed elevated EPS8 expression compared with normal keratinocytes. Using retroviral transduction, we generated HN4 cell lines expressing EPS8 (HN4/EPS8) at levels equivalent to those present in HN12 cells. HN4/EPS8 cells showed increased proliferation and migration compared with controls, together with elevated expression and activity of matrix metalloprotease (MMP)-9, which was dependent on protein kinase B (AKT) activity. Introduction of plasmids that direct synthesis of EPS8 short hairpin RNA (shRNA) into HN12 cells resulted in decreased EPS8 expression in these cells, which correlated with a decrease in their capacity to migrate and invade in vitro. In addition, shRNA-mediated knockdown of EPS8 reduced expression and activity of MMP-9 produced by these cells and reduced MMP-9 promoter activity. EPS8 knockdown cells showed decreased tumorigenicity in vivo compared with controls and lower MMP-9 expression. Conversely, overexpression of EPS8 in HN4 cells was sufficient to induce growth of these non-tumorigenic cells in orthotopic transplantation assays. Furthermore, EPS8 expression in clinical samples of squamous cell carcinoma showed variable expression levels and broadly paralleled expression of MMP-9. The data support a role for EPS8 in squamous carcinogenesis.

[1]  T. Giese,et al.  Eps8 is increased in pancreatic cancer and required for dynamic actin-based cell protrusions and intercellular cytoskeletal organization. , 2007, Cancer letters.

[2]  Yun-Ju Chen,et al.  EPS8 Facilitates Cellular Growth and Motility of Colon Cancer Cells by Increasing the Expression and Activity of Focal Adhesion Kinase* , 2007, Journal of Biological Chemistry.

[3]  P. Slootweg,et al.  Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[4]  Gabriela Kalna,et al.  Divergent routes to oral cancer. , 2006, Cancer research.

[5]  C. R. Leemans,et al.  Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma , 2006, Journal of Clinical Pathology.

[6]  W. A. Yeudall,et al.  Down-regulation of CXCL5 inhibits squamous carcinogenesis. , 2006, Cancer research.

[7]  Jun Yao,et al.  Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. , 2006, Cancer research.

[8]  W. A. Yeudall,et al.  Growth factor-sensitive molecular targets identified in primary and metastatic head and neck squamous cell carcinoma using microarray analysis. , 2006, Oral oncology.

[9]  Jeffrey R. Miller,et al.  Regulation of actin cytoskeleton architecture by Eps8 and Abi1 , 2005, BMC Cell Biology.

[10]  W. A. Yeudall,et al.  Uncoupling of epidermal growth factor-dependent proliferation and invasion in a model of squamous carcinoma progression. , 2005, Oral oncology.

[11]  C. Tacchetti,et al.  A novel actin barbed-end-capping activity in EPS-8 regulates apical morphogenesis in intestinal cells of Caenorhabditis elegans , 2004, Nature Cell Biology.

[12]  Andrea Disanza,et al.  Eps8 controls actin-based motility by capping the barbed ends of actin filaments , 2004, Nature Cell Biology.

[13]  J. Siegfried,et al.  Src Family Kinases Mediate Epidermal Growth Factor Receptor Ligand Cleavage, Proliferation, and Invasion of Head and Neck Cancer Cells , 2004, Cancer Research.

[14]  T. Takenawa,et al.  IRSp53/Eps8 Complex Is Important for Positive Regulation of Rac and Cancer Cell Motility/Invasiveness , 2004, Cancer Research.

[15]  A. Pendergast,et al.  Abl Interactor 1 (Abi-1) Wave-Binding and SNARE Domains Regulate Its Nucleocytoplasmic Shuttling, Lamellipodium Localization, and Wave-1 Levels , 2004, Molecular and Cellular Biology.

[16]  H. Yeh,et al.  Participation of p97Eps8 in Src-mediated Transformation* , 2004, Journal of Biological Chemistry.

[17]  A. Ridley.  Rho Proteins and Cancer , 2004, Breast Cancer Research and Treatment.

[18]  B. Seed,et al.  A PCR primer bank for quantitative gene expression analysis. , 2003, Nucleic acids research.

[19]  G. Scita,et al.  The eps8 family of proteins links growth factor stimulation to actin reorganization generating functional redundancy in the Ras/Rac pathway. , 2003, Molecular biology of the cell.

[20]  S. Husson,et al.  Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. , 2003, European journal of biochemistry.

[21]  Takashi Matsumoto,et al.  Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis. , 2003, Cancer research.

[22]  G. Scita,et al.  Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1 , 2003, The Journal of cell biology.

[23]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[24]  Giorgio Scita,et al.  Mechanisms through which Sos-1 coordinates the activation of Ras and Rac , 2002, The Journal of cell biology.

[25]  C Eng,et al.  Gene expression in papillary thyroid carcinoma reveals highly consistent profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Timpson,et al.  Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity , 2001, Current Biology.

[27]  F. Giancotti,et al.  EGF-R signaling through Fyn kinase disrupts the function of integrin α6β4 at hemidesmosomes , 2001, The Journal of Cell Biology.

[28]  G. Scita,et al.  An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin–polymerizing machine , 2001, The Journal of cell biology.

[29]  Alan Wells,et al.  Membrane Proximal ERK Signaling Is Required for M-calpain Activation Downstream of Epidermal Growth Factor Receptor Signaling* , 2001, The Journal of Biological Chemistry.

[30]  P. Speight,et al.  αvβ6integrin promotes invasion of squamous carcinoma cells through up‐regulation of matrix metalloproteinase‐9 , 2001 .

[31]  P. Speight,et al.  αvβ6 Integrin Upregulates Matrix Metalloproteinase 9 and Promotes Migration of Normal Oral Keratinocytes , 2001 .

[32]  K. Rottner,et al.  The Abl interactor proteins localize to sites of actin polymerization at the tips of lamellipodia and filopodia , 2001, Current Biology.

[33]  Jiahua Xu,et al.  Rac1 Mediates Type I Collagen-dependent MMP-2 Activation , 2001, The Journal of Biological Chemistry.

[34]  David A. Williams,et al.  Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Ullrich,et al.  The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. , 2001, Endocrine-related cancer.

[36]  J. Gillespie,et al.  Gene expression profiles in squamous cell carcinomas of the oral cavity: use of laser capture microdissection for the construction and analysis of stage-specific cDNA libraries. , 2000, Oral oncology.

[37]  R. Mamillapalli,et al.  Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases , 2000, Current Biology.

[38]  H. Modjtahedi,et al.  Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. , 2000, Cancer research.

[39]  D. Lauffenburger,et al.  Shaping up for shipping out: PLCgamma signaling of morphology changes in EGF-stimulated fibroblast migration. , 1999, Cell motility and the cytoskeleton.

[40]  E. Parkinson,et al.  Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells , 1999, Oncogene.

[41]  C. Betsholtz,et al.  EPS8 and E3B1 transduce signals from Ras to Rac , 1999, Nature.

[42]  W. A. Yeudall,et al.  P53 and cyclin D1 staining patterns of malignant and premalignant oral lesions in age-dependent populations. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[43]  M. Maa,et al.  Enhancement of tyrosyl phosphorylation and protein expression of eps8 by v-Src. , 1999, Biochimica et biophysica acta.

[44]  D A Lauffenburger,et al.  Epidermal growth factor alters fibroblast migration speed and directional persistence reciprocally and in a matrix-dependent manner. , 1998, Journal of cell science.

[45]  W. Yeudall,et al.  Functional characterization of p53 molecules expressed in human squamous cell carcinomas of the head and neck , 1997, Molecular carcinogenesis.

[46]  W. A. Yeudall,et al.  Functional characterization in vivo of mutant p53 molecules derived from squamous cell carcinomas of the head and neck , 1997, Molecular carcinogenesis.

[47]  B. Ozanne,et al.  A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer , 1997, Oncogene.

[48]  S. Jackson,et al.  Calpain Cleavage of Focal Adhesion Proteins Regulates the Cytoskeletal Attachment of Integrin αIIbβ3 (Platelet Glycoprotein IIb/IIIa) and the Cellular Retraction of Fibrin Clots* , 1997, The Journal of Biological Chemistry.

[49]  C. Piccoli,et al.  Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth , 1997, Oncogene.

[50]  G. Nolan,et al.  Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. , 1996, Human gene therapy.

[51]  W. A. Yeudall,et al.  Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells. , 1996, Oncogene.

[52]  L. Hennighausen,et al.  Understanding mammary gland development through the imbalanced expression of growth regulators , 1996, Developmental dynamics : an official publication of the American Association of Anatomists.

[53]  Xiaoping Du,et al.  Calpain Cleavage of the Cytoplasmic Domain of the Integrin β2 Subunit (*) , 1995, The Journal of Biological Chemistry.

[54]  S. Goff,et al.  Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. , 1995, Genes & development.

[55]  L. Hennighausen,et al.  Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. , 1995, Development.

[56]  P. Pelicci,et al.  Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation , 1995, Molecular and cellular biology.

[57]  J. Ensley,et al.  Tyrosine phosphorylation as a marker for aberrantly regulated growth‐promoting pathways in cell lines derived from head and neck malignancies , 1995, International journal of cancer.

[58]  W. A. Yeudall,et al.  MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. , 1994, Carcinogenesis.

[59]  A. Ridley.  Membrane ruffling and signal transduction , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[60]  L. Minichiello,et al.  Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF‐dependent mitogenic signals. , 1993, The EMBO journal.

[61]  W. A. Yeudall,et al.  Autocrine production of TGF-α and TGF-β during tumour progression of rat oral keratinocytes , 1993 .

[62]  N. Fusenig,et al.  Progressive abrogation of TGF‐β‐1 and EGF growth control is associated with tumour progression in ras‐transfected human keratinocytes , 1992, International journal of cancer.

[63]  Anne J. Ridley,et al.  The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors , 1992, Cell.

[64]  Anne J. Ridley,et al.  The small GTP-binding protein rac regulates growth factor-induced membrane ruffling , 1992, Cell.

[65]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[66]  B. Gusterson,et al.  Over‐expression of the EGF receptor is a hallmark of squamous cell carcinomas , 1986, The Journal of pathology.

[67]  Vivian Wai Yan Lui,et al.  EGFR-mediated cell cycle regulation. , 2002, Anticancer research.

[68]  M. Maa,et al.  Overexpression of p97Eps8 leads to cellular transformation: implication of pleckstrin homology domain in p97Eps8-mediated ERK activation , 2001, Oncogene.

[69]  D. Crowe,et al.  Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression. , 2001, Neoplasia.

[70]  W. Yeudall,et al.  Epidermal growth factor and transforming growth factor alpha characteristics of human oral carcinoma cell lines. , 1994, British Journal of Cancer.

[71]  A. Ridley,et al.  Distinct patterns of actin organization regulated by the small GTP-binding proteins Rac and Rho. , 1992, Cold Spring Harbor symposia on quantitative biology.